(Total Views: 487)
Posted On: 05/21/2021 4:46:05 PM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
The FDA should be asked to explain why Leronlimab was limited to 2 doses for Covid trials while it does not object at all for HIV trials or cancer trials with patients receiving leronlimab for years
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)